- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/06 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies from serum
Patent holdings for IPC class C07K 16/06
Total number of patents in this class: 1095
10-year publication summary
|
73
|
88
|
131
|
107
|
89
|
108
|
84
|
62
|
55
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2713 |
42 |
| Regeneron Pharmaceuticals, Inc. | 4647 |
39 |
| Genentech, Inc. | 4092 |
35 |
| Amgen Inc. | 4385 |
35 |
| Cytiva BioProcess R&D AB | 320 |
33 |
| CSL Behring AG | 186 |
31 |
| Hoffmann-La Roche Inc. | 3738 |
30 |
| F. Hoffmann-La Roche AG | 7843 |
29 |
| Biotest AG | 107 |
19 |
| Bristol-myers Squibb Company | 4774 |
13 |
| Plasma Technologies, LLC | 25 |
12 |
| ADMA Biomanufacturing, LLC | 31 |
12 |
| AbbVie Biotechnology Ltd. | 178 |
11 |
| Janssen Biotech, Inc. | 1740 |
11 |
| The Johns Hopkins University | 5849 |
10 |
| Bio-Rad Laboratories, Inc. | 1615 |
10 |
| Momenta Pharmaceuticals, Inc. | 292 |
10 |
| The Rockefeller University | 580 |
10 |
| EMD Millipore Corporation | 634 |
9 |
| Laboratoire Francais du Fractionnement et des Biotechnologies | 296 |
9 |
| Other owners | 685 |